Abbott India Ltd.

NSE: ABBOTINDIA | BSE: 500488 | ISIN: INE358A01014 | Industry: Pharmaceuticals
| Expensive Performer
28030.0000 -455.00 (-1.60%)
NSE Jan 02, 2026 13:46 PM
Volume: 7,227
 

logo
Abbott India Ltd.
16 May 2025
28030.00
-1.60%
ICICI Securities Limited
Abbott India’s (Abbott) revenue grew 12% YoY ahead of most MNCs (avg. growth of ~10% YoY and IPM growth of ~8% YoY in Q4FY25). Abbott’s growth was aided by healthy traction in its own brands along with key brands of Novo Nordisk like Rybelsus and Ryzodeg.
Abbott India Ltd. has an average target of 34729.60 from 5 brokers.
More from Abbott India Ltd.
Recommended